Company Overview
Ambey Laboratories Limited, established in 1985, is a prominent player in the manufacturing of various chemical products, including surfactants, specialty chemicals, and intermediates. The company has its registered office in South West Delhi and a corporate office in Gurugram, Haryana. The promoters of the company are Archit Gupta, Arpit Gupta, Sarina Gupta, and Rishita Gupta. Over the years, Ambey Laboratories has built a solid reputation for delivering high-quality chemical products catering to a wide range of industries such as textiles, pharmaceuticals, and agrochemicals.
Ambey Laboratories Financial Performance
Ambey Laboratories has demonstrated consistent financial growth over the past few years. Here is a summary of the financial highlights from the Draft Red Herring Prospectus (DRHP):
| Period Ended |
Assets (Cr) |
Revenue (Cr) |
Profit After Tax (Cr) |
Net Worth (Cr) |
Reserves and Surplus (Cr) |
Total Borrowing (Cr) |
| 31 Jan 2024 |
86.21 |
100.44 |
6.08 |
34.31 |
15.62 |
20.05 |
| 31 Mar 2023 |
57.62 |
107.43 |
4.57 |
23.64 |
5.89 |
13.65 |
| 31 Mar 2022 |
55.93 |
85.11 |
3.57 |
19.07 |
1.32 |
18.05 |
| 31 Mar 2021 |
44.62 |
82.42 |
10.34 |
-7.86 |
-12.76 |
32.93 |
Ambey Laboratories IPO Details
Important Dates
| Event |
Date |
| IPO Open Date |
July 3, 2024 |
| IPO Close Date |
July 5, 2024 |
| Basis of Allotment |
July 8, 2024 |
| Initiation of Refunds |
July 9, 2024 |
| Credit of Shares to Demat |
July 9, 2024 |
| Listing Date |
July 10, 2024 |
Key IPO Information of Ambey Laboratories Limited:
| Detail |
Information |
| Face Value |
₹10 per share |
| Price Band |
₹65 to ₹68 per share |
| Lot Size |
2000 shares |
| Total Issue Size |
6,864,000 shares (aggregating up to ₹46.68 Cr) |
| Fresh Issue |
6,552,000 shares (aggregating up to ₹44.55 Cr) |
| Offer for Sale |
312,000 shares (aggregating up to ₹2.12 Cr) |
| Listing At |
NSE SME |
Subscription Details
The subscription details will be updated once the IPO opens for bidding. Investors can track the subscription status for different categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs) to gauge the market interest in the IPO.
Subscription Stats
Once the IPO opens, the subscription status will be updated regularly. The table below will provide detailed information on the subscription levels across various investor categories.
| Category |
Subscription (times) |
| QIB |
0.41 |
| NII |
50.15 |
| Retail |
64.06 |
| Total |
42.26 |
Ambey Laboratories IPO Grey Market Premium (GMP)
The Grey Market Premium (GMP) will be monitored and updated regularly. GMP provides insight into the market's perception of the IPO and potential listing gains. Stay tuned for the latest updates.
GMP Rates
The table below will provide the latest GMP rates as the IPO progresses:
| Date |
IPO GMP |
| 4 July |
₹30 |
| 5 July |
₹40 |
| 6 July |
₹42 |
| - |
- |
| - |
- |
Conclusion
Ambey Laboratories Limited IPO presents a promising opportunity for investors looking to invest in a company with a strong financial track record and significant growth potential in the chemical manufacturing sector. The steady financial performance, coupled with strategic use of IPO proceeds for expansion and debt reduction, positions the company for sustained growth. Potential investors should consider their investment objectives and risk appetite before subscribing to the IPO.
Headlines:
- "Ambey Laboratories Limited IPO Review: Key Dates, Financials, and Subscription Details"
- "Invest in Ambey Laboratories Limited IPO: Comprehensive Guide and Analysis"
- "Ambey Laboratories Limited IPO: GMP, Subscription Stats, and Financial Performance"
- "Everything You Need to Know About Ambey Laboratories Limited IPO"
- "Ambey Laboratories Limited IPO: Detailed Review and Key Insights"
- "Ambey Laboratories Limited IPO: Key Information, Dates, and Investment Analysis"
- "Ambey Laboratories Limited IPO: A Deep Dive into Financials and Market Potential"
- "Ambey Laboratories Limited IPO Subscription and GMP Updates"